Repeat pull from proven relationships plus room left

Pediatrix Medical Group, Inc. (MD) — this company's answers

The model's full reasoning — Q3 2021 call → NOWe need to determine if management describes existing counterparties (customers, accounts, partners) that have already been served and proven themselves, and that these counterparties are currently, on their own initiative, taking or committing to meaningfully more than before (expansion), and that these relationships remain lightly penetrated with substantial room for more. Look for evidence in the transcript. Management discusses growth efforts: expanding practices, adding practices, enhancing hospital relationships, coordination of subspecialties. They mention acquisitions, organic growth. They mention Brave Care investment for pediatric clinics. They mention "we estimate that we have added approximately three percentage points to our adjusted EBITDA growth versus 2020, over and above the pure same-store growth that our affiliated practices have experienced." That suggests some growth from existing practices? But is it from existing counterparties taking more? They talk about "target opportunities to expand practices or add practices and enhance our hospital relationships" - that could be new or existing. They mention "coordination of different subspecialties that many patients need to access" - that might be cross-selling to existing patients? But is that from existing hospital partners? They talk about "our patient service access initiatives, improving technology support, improving revenue cycle management efficiency, recruiting the best talent, and old-fashioned focused managerial actions." That seems like internal improvements, not necessarily counterparties taking more. They mention "we recently announced our investment in Brave Care" - that's a new venture, not existing relationships. They talk about "we have a nucleus from which we can grow" with NightLight acquisition - that's an acquisition, not existing. They mention "we're already in discussions with certain existing platforms that we think overlap well with us" - that's potential acquisitions. So the growth seems to be from new practices, acquisitions, and internal efficiency, not necessarily from existing hospital partners or payers taking more volume. They do mention "total births at the hospitals where we provide NICU services were up 2.8% on a same-unit basis" - that's volume growth at existing hospitals.

← Back to the full MD analysis